These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 14695186

  • 1. ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity.
    Angèle S, Romestaing P, Moullan N, Vuillaume M, Chapot B, Friesen M, Jongmans W, Cox DG, Pisani P, Gérard JP, Hall J.
    Cancer Res; 2003 Dec 15; 63(24):8717-25. PubMed ID: 14695186
    [Abstract] [Full Text] [Related]

  • 2. Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy.
    Moullan N, Cox DG, Angèle S, Romestaing P, Gérard JP, Hall J.
    Cancer Epidemiol Biomarkers Prev; 2003 Nov 15; 12(11 Pt 1):1168-74. PubMed ID: 14652276
    [Abstract] [Full Text] [Related]

  • 3. Functional consequences of ATM sequence variants for chromosomal radiosensitivity.
    Gutiérrez-Enríquez S, Fernet M, Dörk T, Bremer M, Lauge A, Stoppa-Lyonnet D, Moullan N, Angèle S, Hall J.
    Genes Chromosomes Cancer; 2004 Jun 15; 40(2):109-19. PubMed ID: 15101044
    [Abstract] [Full Text] [Related]

  • 4. The XRCC1 -77T->C variant: haplotypes, breast cancer risk, response to radiotherapy and the cellular response to DNA damage.
    Brem R, Cox DG, Chapot B, Moullan N, Romestaing P, Gérard JP, Pisani P, Hall J.
    Carcinogenesis; 2006 Dec 15; 27(12):2469-74. PubMed ID: 16829685
    [Abstract] [Full Text] [Related]

  • 5. Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma.
    Akulevich NM, Saenko VA, Rogounovitch TI, Drozd VM, Lushnikov EF, Ivanov VK, Mitsutake N, Kominami R, Yamashita S.
    Endocr Relat Cancer; 2009 Jun 15; 16(2):491-503. PubMed ID: 19286843
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Haplotype-based analysis of genes associated with risk of adverse skin reactions after radiotherapy in breast cancer patients.
    Suga T, Ishikawa A, Kohda M, Otsuka Y, Yamada S, Yamamoto N, Shibamoto Y, Ogawa Y, Nomura K, Sho K, Omura M, Sekiguchi K, Kikuchi Y, Michikawa Y, Noda S, Sagara M, Ohashi J, Yoshinaga S, Mizoe J, Tsujii H, Iwakawa M, Imai T.
    Int J Radiat Oncol Biol Phys; 2007 Nov 01; 69(3):685-93. PubMed ID: 17889263
    [Abstract] [Full Text] [Related]

  • 8. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F, Labrie Y, Soucy P, Sinilnikova O, Labuda D, Bessette P, Chiquette J, Laframboise R, Lépine J, Lespérance B, Ouellette G, Pichette R, Plante M, Tavtigian SV, Simard J.
    BMC Cancer; 2006 Sep 29; 6():230. PubMed ID: 17010193
    [Abstract] [Full Text] [Related]

  • 9. Polymorphisms in the Janus kinase 2 (JAK)/signal transducer and activator of transcription (STAT) genes: putative association of the STAT gene region with familial breast cancer.
    Vaclavicek A, Bermejo JL, Schmutzler RK, Sutter C, Wappenschmidt B, Meindl A, Kiechle M, Arnold N, Weber BH, Niederacher D, Burwinkel B, Bartram CR, Hemminki K, Försti A.
    Endocr Relat Cancer; 2007 Jun 29; 14(2):267-77. PubMed ID: 17639043
    [Abstract] [Full Text] [Related]

  • 10. A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression.
    De Feo E, Persiani R, La Greca A, Amore R, Arzani D, Rausei S, D'Ugo D, Magistrelli P, van Duijn CM, Ricciardi G, Boccia S.
    Mutat Res; 2009 Apr 30; 675(1-2):60-5. PubMed ID: 19386249
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity.
    Willems P, Claes K, Baeyens A, Vandersickel V, Werbrouck J, De Ruyck K, Poppe B, Van den Broecke R, Makar A, Marras E, Perletti G, Thierens H, Vral A.
    Genes Chromosomes Cancer; 2008 Feb 30; 47(2):137-48. PubMed ID: 18000863
    [Abstract] [Full Text] [Related]

  • 15. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
    Sprague BL, Trentham-Dietz A, Garcia-Closas M, Newcomb PA, Titus-Ernstoff L, Hampton JM, Chanock SJ, Haines JL, Egan KM.
    Carcinogenesis; 2007 Aug 30; 28(8):1680-6. PubMed ID: 17449902
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk.
    Lee KM, Choi JY, Park SK, Chung HW, Ahn B, Yoo KY, Han W, Noh DY, Ahn SH, Kim H, Wei Q, Kang D.
    Cancer Epidemiol Biomarkers Prev; 2005 Apr 30; 14(4):821-5. PubMed ID: 15824150
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
    Ahirwar D, Mandhani A, Mittal RD.
    Arch Med Res; 2009 Feb 30; 40(2):97-102. PubMed ID: 19237018
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.